Clene to include ALS biomarker data in NDA for accelerated approval
Go back to Clene to include ALS biomarker data in NDA for accelerated approval| (NASDAQ: CLNN) | Delayed: 3.85 +0.09 (2.39%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $3.76 | 52 Week High | $ | |||
| Open | $3.73 | 52 Week Low | $ | |||
| Day High | $4.01 | P/E | N/A | |||
| Day Low | $3.73 | EPS | $ | |||
| Volume | 72,440 | |||||



